Mélissa obtained her PhD in Biology and Health from the University of Clermont Auvergne in 2022, after conducting research on Crohn’s disease, and more specifically on the interaction between the bacteria involved in this disease and the intestinal epithelium.
After a post-doctorate at the Cochin Institute (Paris), Mélissa joined the Théa Open Innovation team in June 2024 as Scientific Assessment Officer.